ReviewJournal of hematology & oncology2013

Targeting mitochondrial reactive oxygen species as novel therapy for inflammatory diseases and cancers.

Xinyuan Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.